Dry Powder Nasal Delivery of Emergency Use Medications

NCBiotech Grants & Loans

See the full listing of all NCBiotech grants and loans awarded since July 2012.

Belhaven Biopharma, Inc.
Award Date
Award Amount
Program Name
Strategic Growth Loan
Program Category
Business Financing
Principal Investigator
Scott Lyman
Fiscal Year
Research Triangle
Project Description:

Belhaven Pharmaceuticals is developing a dry powder intranasal epinephrine for the treatment of anaphylaxis. The SGL funds will be used for clinical trial material scale-up and production, IND preparation and filing, and a pilot human clinical trial.

scroll back to top of page